期刊文献+

TFP5通过特异性抑制CDK5/p25活性抑制MPP+诱导的PCI2细胞凋亡 被引量:1

TFP5 protects MPP+ induced PC12 cell apoptosis by specifically inhibiting cyclin-dependent kinase 5/p25activity
原文传递
导出
摘要 目的探讨TFP5(p35的一个裂解片段)特异性抑制细胞周期蛋白依赖蛋白激酶5(CDK5)/p25活力后在1-甲基-4-苯基吡啶(MPP+)诱导的PC12细胞凋亡过程中的保护作用及其机制。方法使用100 μg/L β神经生长因子将体外常规培养的PCI2细胞诱导分化为多巴胺能神经元,加入不同浓度MPP+(0、100、200、300、400、600、800、1000 μmol/L)处理,应用CCK8法检测细胞活力,以明确MPP+诱导PC12细胞凋亡的合适浓度。将诱导分化后的PC12细胞分为4组:PBS+PBS组、MPP++PBS组、MPP++TFP5组和MPP++CDK5抑制剂Roscovitine组;TFP5与Roscovitne提前12 h加入培养基中预处理(终浓度分别为100 nmol/L、10 nmol/L)。分别应用流式细胞仪及Hoechst33258染色检测细胞凋亡情况,应用Western blotting检测细胞中p35/p25、半胱氨酸蛋白酶-3、裂解半胱氨酸蛋白酶-3蛋白表达水平。结果CCK8法检测结果显示:MPP+浓度为300 μmol/L时,PC12细胞的存活率为(64.84±1.58)%。流式细胞仪检测结果显示:MPP++PBS组细胞凋亡率[(25.61±2.74)%]最高,MPP++TFP5组细胞凋亡率[(13.33±1.24)%]较低,比较差异有统计学意义(P〈0.05)。Hoechst33258染色结果显示:MPP++PBS组细胞核固缩及碎裂最明显,较多凋亡小体形成,而MPP++TFP5组与MPP++Roscovitine组仅有少量凋亡小体形成。Western blotting检测结果显示:与PBS+PBS组比较,MPP++PBS组、MPP++TFP5组、MPP++Roscovitine组p25蛋白表达水平均明显增高,差异均有统计学意义(P〈0.05)。MPP++PBS组裂解半胱氨酸蛋白酶-3蛋白表达水平较PBS+PBS组明显升高,差异有统计学意义(P〈0.05);MPP++TFP5组裂解半胱氨酸蛋白酶-3蛋白表达水平较MPP++PBS组明显降低,差异有统计学意义(P〈0.05)。结论TFP5通过特异性抑制CDK5/p25表达,减少裂解半胱氨酸蛋白酶-3蛋白的产生,对MPP+诱导的PC12细胞凋亡起抑制作用,从而对细胞产生保护作用。 Objective To determine whether the apoptosis of PC12 cells induced by MPP+ can be protected when the activity ofcyclin-dependent kinase 5(CDK5)/p25 is inhibited specifically by TFP5. Methods The 100 μg/L of beta nerve growth factor (β-NGF) was used to induce PCI2 cells differentiating into dopaminergic neurons in vitro. Different concentrations of MPP+ (0, 100, 200, 300, 400, 600, 800 and 1000μmol/L) were added to the cells; CCK8 assay was used to determine the cell activities and adequate concentration of MPP+. After induction, four groups were designed: PBS and PBS group, MPP+ and PBS group, MPP+ and TFP5 group, and MPP+ and Roscovitine group. Pretreatment of TFP5 and Roscovitne for 12 h was given to the MPP+ and TFP5 group and MPP+ and Roscovitine group, respectively. Hochest33258 staining and flow cytometry were used to detect the cell apoptosis. Western blotting was used to detect the protein expressions ofp35/25, caspase3, cleaved caspase3. Results CCK8 assay showed that the survival rate of PC12 cells was (64.84±1.58)% when the MPP+ concentration was 300 μmol/L. Flow cytometry indicated significant differences in the apoptosis rate between different groups, which was the highest in MPP+ and PBS group ([25.61±2.74]%), following by MPP+ and TFP5 group ([13.33±1.24]%), MPP+ and Roscovitine group ([9.94±1.70]%), and PBS and PBS group ([8.68±0.21]%); significant difference was noted between MPP+ and TFP5 group and MPP+ and Roscovitine group (P〈0.05). Hochest33258 staining indicated the most obvious nucleus condensation and fragmentation and more apoptotic bodies in MPP+ and PBS group, While few apoptotic bodies were found in MPP+ and TFP5 group and MPP+ and Roscovitine group. Western blotting showed that as compared with that in the PBS and PBS group, the p25 protein level in the MPP+ and PBS group, MPP+ and TFP5 group, and MPP+ and Roscovitine group was significantly increased (P〈0.05). The cleaved caspase-3 protein expression in the MPP+ and PBS group was significantly higher than that in the PBS and PBS group (P〈0.05); the cleaved caspase-3 protein expression in the MPP+ and PBS group was significantly higher than that in the MPP+ and TFP5 group (P〈0.05). Coneluslon TFP5 has protective effect against the apoptosis of PC 12 cells induced by MPP+ through inhibiting the CDK5/p25 expression and reducing the cleaved caspase-3 protein production.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2016年第3期261-266,共6页 Chinese Journal of Neuromedicine
基金 广东省自然科学基金(S20130100014233) 广州市海珠区科技计划项目(2013-cg-30)
关键词 帕金森病 TFP5 细胞周期蛋白依赖蛋白激酶5 半胱氨酸蛋白酶-3 Parkinson's disease TFP5 Cyclin-dependent kinase 5 Caspase-3
  • 相关文献

参考文献10

  • 1Su SC, Tsai LH. Cyclin-dependent kinases in brain development and disease[J]. Annu Rev Cell Dev Biol, 2011, 27: 465-491.
  • 2Lee MS, Kwon YT, Li M, et al. Neurotoxicity induces cleavage of p35 to p25 by calpain[J]. Nature, 2000, 405(6784): 360-364.
  • 3Wen Z, Shu Y, Gao C, et al. CDK5-mediated phosphorylation and autophagy of RKIP regulate neuronal death in Parkinson's disease [J]. Neurobiol Aging, 2014, 35(12): 2870-2880.
  • 4Alvira D, Ferrer I, Gutierrez-Cuesta J, et al. Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease[J]. Parkinsonism Relat Disord, 2008, 14(4): 309-313.
  • 5Shukla V, Zheng YL, Mishra SK, et al. A trtmcated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice[J]. FASEB J, 2013, 27(1): 174-186.
  • 6Zhang ZX, Roman GC, Hong Z, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai[J]. Lancet, 365(9459): 595-597.
  • 7Ye J, Liu Z, Wei J, et al. Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via the p53-caspase-3-dependent apoptotic pathway [J]. Neurosci Lett,2013, 553: 72-77.
  • 8Lu XL, Lin YH, Wu Q, et al. Paeonolum protects against MPP(+) -induced neurotoxicity in zebrafish and PC12 cells [J]. BMC Complement Altern Med, 2015, 15: 137.
  • 9Binukumar BK, Zheng YL, Shukla V, et al. TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity[J]. J Atzheimers Dis, 2014, 39(4): 899-909.
  • 10Chiarini A, Liu D, Armato U, et al. Bc110 crucially nucleates the pro-apoptotic complexes comprising PDK1, PKCζ and caspase-3 at the nuclear envelope of etoposide-treated human cervical carcinoma C4-I cells[J]. Int J Mol Med, 2015, 36(3): 845-856.

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部